Roivant Sciences Ltd.

Historical 13F Holders

Symbol
ROIV
CUSIP
G76279101
All holders as of
Q3 2026
Type
Equity
Class
SHS
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for G76279101 since 12/18/2024, largest first.

Filer % of Class Filed
FMR LLC 13G/A
11.8% 11/5/2026
Event 9/30/2026
BlackRock, Inc. 13G/A 8.2% 10/27/2026
Event 9/30/2026
Morgan Stanley 13G/A
5.7% 8/13/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (5)
QVT Financial LP 13G/A 4.3% 8/14/2025
Event 6/30/2025
Ramaswamy Vivek 13G/A 3.6% 5/6/2026
Event 3/31/2026
Viking Global Investors LP 13G/A
3.4% 11/14/2025
Event 9/30/2025
SB Investment Advisers (UK) Ltd 13G/A
2.3% 2/17/2026
Event 12/31/2025
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 525 577 M $21.1B
2026 Q2 505 557 M $19.7B
2026 Q1 454 530 M $14.7B
2025 Q4 410 509 M $11.0B
2025 Q3 350 506 M $7.65B
2025 Q2 346 515 M $5.80B
2025 Q1 320 558 M $5.63B
2024 Q4 324 563 M $6.65B
2024 Q3 302 569 M $6.57B
2024 Q2 301 546 M $5.77B
2024 Q1 263 532 M $5.60B
2023 Q4 230 542 M $6.08B
2023 Q3 210 546 M $6.38B
2023 Q2 183 498 M $5.02B
2023 Q1 148 459 M $3.39B
2022 Q4 113 412 M $3.29B
2022 Q3 80 371 M $1.19B
2022 Q2 73 360 M $1.47B
2022 Q1 54 349 M $1.72B
2021 Q4 43 339 M $3.42B